Iowa HF405 mandates a cap on cost-sharing for prescription insulin drugs in certain health insurance plans.
Iowa HF405 establishes a cap on the cost-sharing amount for prescription insulin drugs in specific health insurance plans. The bill applies to individual or group accident and sickness insurance, hospital or medical service contracts, health maintenance organization contracts, and public employee plans. It mandates that the total cost-sharing for a 31-day supply of rapid-acting, short-acting, intermediate-acting, or long-acting prescription insulin drugs cannot exceed $25.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.